Research and News Involving:
Dr. Fleischman



Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition

Press Release: Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Finalists Announced for CureAccelerator Live! for Rare Diseases 2020 Competition Virtual Pitch Event on June 11 Features 5 Clinical Repurposing Projects April 21, 2020...

Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases

Press Release: University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases University of California, Irvine Researcher Wins CureAccelerator Live! for Rare Diseases Clinical Trial in Myeloproliferative Neoplasms Receives Funding to...

Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with N-Acetylcysteine

Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with N-Acetylcysteine Principal Investigator: Dr. Angela Fleischman​ Disease: Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia and myelofibrosis Research Description:...